Clinical challenges in lipid disorders /
Lipid disorders are highly heterogeneous and widely prevalent throughout the world. Dyslipidemia is an important risk factor for atherosclerotic disease and its clinical sequelae, including myocardial infarction, ischemic stroke, and death. The impact of dyslipidemia treatment on risk for cardiovasc...
| Основен автор: | Toth, Peter P. |
|---|---|
| Други автори: | Sica, Domenic A. |
| Формат: | Електронна книга |
| Език: | English |
| Публикувано: |
Oxford :
Clinical Pub.,
℗♭2008.
|
| Серия: |
Clinical challenges.
|
| Предмети: | |
| Онлайн достъп: |
http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=244612 |
| Подобни документи: |
Print version::
Clinical challenges in lipid disorders. |
Съдържание:
- 7. Metabolism of apolipoprotein B-100-containing lipoproteins in dyslipidaemias8. Sex-specific aspects of dyslipidaemia and atherosclerosis; Part III: Prevention and treatment strategies; 9. New clinical trials oflipid-regulating agents; 10. Genetics of dyslipidaemia andcoronary risk (personalized lipid-lowering treatment); 11. Application of proteomic, metabolomic and lipidomic approaches to coronary heart disease risk prediction; 12. N.